Viewing Study NCT07325292


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-30 @ 3:03 AM
Study NCT ID: NCT07325292
Status: RECRUITING
Last Update Posted: 2026-03-23
First Post: 2025-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module